Export this Abstract | Print this Abstract | Add to my preferred Abstracts list | My preferred Abstracts list (0) | Back to Search
SOLITHROMYCIN VERSUS FLUOROQUINOLONES FOR PNEUMONIA CAUSED BY ATYPICAL BACTERIA: A META-ANALYSIS
- At: 2019 FIP Congress in AbuDhabi (United Arab Emirates)
- Type: Poster
- By: ELJAALY, Khalid (King Abdulaziz University, Pharmacy Practice, Saudi Arabia)
- Co-author(s): Khalid Eljaaly: Pharmacy Practice, King Abdulaziz University, Jeddah, Saudi Arabia;Pharmacy Practice & Science, University of Arizona, Tucson, United States
Samah Alshehri: Pharmacy Practice, King Abdulaziz University, Jeddah, Saudi Arabia;Pharmacy Practice & Science, University of Arizona, Tucson, United States
BackgroundThe clinical practice guidelines recommend empiric coverage of atypical bacteria in patients with community-acquired pneumonia (CAP). Solithromycin is a novel ketolide antibiotic which has not been yet approved for CAP.
MethodsTwo researchers independently searched the PubMed, EMBASE and Cochrane Library databases for relevant.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.
Last update 4 October 2019